Exercise interventions on patients with end-stage renal disease: a systematic review.

Saved in:
Bibliographic Details
Title: Exercise interventions on patients with end-stage renal disease: a systematic review.
Authors: Zhao, Qiu-Ge, Zhang, Hong-Rui, Wen, Xin, Wang, Yu, Chen, Xue-Mei, Chen, Niu, Sun, Ying, Liu, Han, Lu, Ping-Jing
Source: Clinical Rehabilitation. Feb2019, Vol. 33 Issue 2, p147-156. 10p. 1 Diagram, 7 Charts, 1 Graph.
Subjects: Anxiety, Chronic kidney failure, Mental depression, Exercise therapy, Fatigue (Physiology), Information storage & retrieval systems, Medical databases, Medical information storage & retrieval systems, MEDLINE, Meta-analysis, Online information services, Quality of life, Systematic reviews, Physical activity, Data analysis software
Abstract: Objective: This study aimed to conduct an up-to-date systematic review of the literature to evaluate the effects of exercise on fatigue, anxiety, depression, physical activity, and quality of life (QOL) in patients with end-stage renal disease. Data sources: We searched PubMed (October 2018), Embase (from 1966 to October 2018), Web of Science (from 1900 to October 2018), The Cochrane Library (October 2018), and references of papers. Methods: This study includes randomized controlled trials that analyzed the combined effects of exercise intervention on patients with end-stage renal disease. Two reviewers independently screened the retrieved records, extracted data, and assessed the risk of bias for inclusion in the study. The effects of exercise intervention were conducted in the meta-analysis using RevMan 5.3 software. Results: A total of 614 participants were included in 13 randomized controlled studies. The study revealed that exercise can improve fatigue, anxiety, depression, physical activity, and QOL. The effect value results were as follows: (1) fatigue, −0.97 (95% confidence interval (CI) −1.32 to −0.62, P < 0.00001); (2) anxiety, −0.78 (95% CI −1.17 to −0.39, P < 0.0001); (3) depression, −0.85 (95% CI −1.13 to −0.56, P < 0.00001) (4) physical activity, 38.15 (95% CI 21.20 to 55.10, P < 0.0001); (5) QOL, the physical component of the 36-item Short-Form Health Survey (SF-36), 4.73 (95% CI 1.92 to 7.54, P = 0.0010); and (6) the mental component of the SF-36, 3.42 (95% CI 0.27 to 6.56, P = 0.03). Conclusion: Exercise intervention is more effective in fatigue, anxiety, depression, physical activity, and QOL. However, large-scale randomized controlled trials are needed to confirm the appropriate types of exercise and optimal time for patients with end-stage renal disease. [ABSTRACT FROM AUTHOR]
Copyright of Clinical Rehabilitation is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
Description
Abstract:Objective: This study aimed to conduct an up-to-date systematic review of the literature to evaluate the effects of exercise on fatigue, anxiety, depression, physical activity, and quality of life (QOL) in patients with end-stage renal disease. Data sources: We searched PubMed (October 2018), Embase (from 1966 to October 2018), Web of Science (from 1900 to October 2018), The Cochrane Library (October 2018), and references of papers. Methods: This study includes randomized controlled trials that analyzed the combined effects of exercise intervention on patients with end-stage renal disease. Two reviewers independently screened the retrieved records, extracted data, and assessed the risk of bias for inclusion in the study. The effects of exercise intervention were conducted in the meta-analysis using RevMan 5.3 software. Results: A total of 614 participants were included in 13 randomized controlled studies. The study revealed that exercise can improve fatigue, anxiety, depression, physical activity, and QOL. The effect value results were as follows: (1) fatigue, −0.97 (95% confidence interval (CI) −1.32 to −0.62, P < 0.00001); (2) anxiety, −0.78 (95% CI −1.17 to −0.39, P < 0.0001); (3) depression, −0.85 (95% CI −1.13 to −0.56, P < 0.00001) (4) physical activity, 38.15 (95% CI 21.20 to 55.10, P < 0.0001); (5) QOL, the physical component of the 36-item Short-Form Health Survey (SF-36), 4.73 (95% CI 1.92 to 7.54, P = 0.0010); and (6) the mental component of the SF-36, 3.42 (95% CI 0.27 to 6.56, P = 0.03). Conclusion: Exercise intervention is more effective in fatigue, anxiety, depression, physical activity, and QOL. However, large-scale randomized controlled trials are needed to confirm the appropriate types of exercise and optimal time for patients with end-stage renal disease. [ABSTRACT FROM AUTHOR]
ISSN:02692155
DOI:10.1177/0269215518817083